Benitec Biopharma

BNTC

Market cap $399M

11.65 USD

-0.05

0.43%

At close Updated Feb 11, 4:00 PM EST

Pre-market

After hours

11.65

0.00

1 day

-0.43%

5 days

-5.44%

1 month

-4.04%

3 months

-12.14%

6 months

-2.1%

Year to date

-7.47%

1 year

12.02%

5 years

-86.18%

10 years

-98.68%

About: Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Employees: 19

Healthcare Biotechnology